Skip to main content
. 2022 Jan 12;8:815628. doi: 10.3389/fmed.2021.815628

Table 5.

Risk factors of early recurrence (in 3-year) of ovarian endometrioma in univariate and multivariate analysis.

≤ 3 years
(n = 87)
>3 years
(n = 146)
Univariate analysis p-value Multivariate analysis OR (95%CI) p -value
Age, y 35.26 ± 3.26 36.17± 4.18 0.38
BMI, kg/m2 22.78 ± 3.44 23.14 ± 3.08 0.23
Nullgravidy (n, %) 28 (32.18) 47 (32.19) 0.61
Nullparity (n, %) 32 (36.78) 52 (35.62) 0.54
Postoperative GnRH therapy (n, %) 42 (48.28) 72 (49.32) 0.42
Postoperative LNG-IUD insertion (n, %) 45 (51.72) 75 (51.37) 0.71
Endometrioma surgery history (n, %) 17 (19.54) 30 (20.55) 0.29
Leiomyoma (n, %) 17 (19.54) 32 (21.92) 0.77
Pain symptom (n, %) 61 (70.11) 65 (44.52) 0.024 1.6 (0.8–2.3) 0.09
VAS of pain symptom 7.28 ± 1.72 5.76 ± 1.29 0.029 1.5 (0.7–2.7) 0.21
Extrinsic adenomyosis (n, %) 53 (60.92) 59 (40.41) <0.01 2.5 (1.2–3.4) <0.01
DIE (n, %) 69 (79.31) 77 (52.74) 0.018 2.1 (1.4–2.8) 0.012
Primary infertility (n, %) 32 (36.78) 18 (12.32) 0.012 1.8 (1.3–4.3) 0.011
Secondary infertility (n, %) 7 (8.05) 13 (8.90) 0.56 2.2 (0.6–3.8) 0.37
Extrinsic adenomyosis with DIE (n, %) 42 (48.28) 26 (17.81) <0.01 3.8 (2.1–5.6) <0.01
Extrinsic adenomyosis with primary infertility (n, %) 28 (32.18) 10 (6.85) <0.01 3.2 (2.2–5.1) <0.01

OR, odds ratio, CI, confidence interval, a multiple logistic regression analysis. p < 0.05.